Document is current
Any future updates will be listed below
-
Authors
Pennlund, Anna
Olsson Bontell, Thomas
Skoglund, Thomas
Carén, Helena
Johannsson, Gudmundur
Olsson, Daniel S.
Esposito, Daniela
-
Funding
Funding for this research was provided by:
University of Gothenburg
- License Information
-
More Information
Article History
Received: 12 February 2026
Accepted: 4 May 2026
First Online: 23 May 2026
Declarations
:
: The study was approved by the Swedish Ethical Review Authority (Etikprövningsmyndigheten) (Dnr: 2019-04779).
: A.P., T.O.B., H.C. and T.S. has no conflict of interest to declare. D.S.O. is an employee at AstraZeneca as of 30 August 2021. G.J. has served as a consultant for Novo Nordisk, Crinetics, and AstraZeneca and has received lecture fees from Ascendis Pharma, Novo Nordisk, Pfizer, and Pharmanova. D.E. has received lecture fees from Ipsen, Recordati, and Pfizer AB.
